REQUEST A DEMO
Total
USD $0.00
Search more companies

Centurion Pharma Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Centurion Pharma Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Centurion Pharma Ilac A.S. is based in Turkiye, with the head office in Istanbul. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on June 01, 2001. 3 (2023) employees currently work for Centurion Pharma Ilac A.S.. There was a net sales revenue drop of 49.32% reported in Centurion Pharma Ilac A.S.’s latest financial highlights for 2020. Over the same period, its total assets grew by 28.29%. The net profit margin of Centurion Pharma Ilac A.S. increased by 1.87% in 2020.

Headquarters
No:1-17 Maslak Mahallesi Eski Buyukdere Caddesi Sariyer
Istanbul; Marmara; Postal Code: 34485

Contact Details: Purchase the Centurion Pharma Ilac A.S. report to view the information.

Website: http://www.centurion.com.tr

Basic Information
Total Employees:
Purchase the Centurion Pharma Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Centurion Pharma Ilac A.S. report to view the information.
Incorporation Date:
June 01, 2001
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Centurion Pharma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-49.32%
Total operating revenue
-49.32%
Operating profit (EBIT)
-64.09%
Net Profit (Loss) for the Period
-39.84%
Total assets
28.29%
Total equity
30.31%
Operating Profit Margin (ROS)
-8.52%
Net Profit Margin
1.87%
Return on Equity (ROE)
-27.12%
Debt to Equity Ratio
-36.06%
Quick Ratio
0.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?